{"content":"<li class=\"n-box-item date-title\" data-end=\"1514609999\" data-start=\"1514523600\" data-txt=\"Monday, December 23, 2019\">Friday, December 29, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3320475\" data-ts=\"1514575287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADTN\" target=\"_blank\">ADTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320475-adtranminus-14-after-warning-on-q4-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adtran -14% after warning on Q4 earnings</a></h4><ul>     <li>Adtran (<a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a> <font color='red'>-14.3%</font>) plunges to a 52-week low after <a href=\"https://seekingalpha.com/pr/17034981-adtran-inc-announces-revised-fourth-quarter-revenue-earnings-estimate\" target=\"_blank\">issuing below consensus guidance</a> for Q4, revising its revenue estimate to $125M from $155M-$165M earlier and seeing EPS of ~$0.01; analysts had expected EPS of ~$0.14 and revenue of $161.2M.</li>     <li>ADTN also expects Q1 to come in at roughly the same as Q4, below analyst consensus of $167.5M.</li>     <li>CEO Tom Stanton says Q4 results have been hurt by a merger-related review, which ADTN expects to be completed in 60-90 days, and slowdown in the spending at a domestic Tier 1 customer.</li>     <li>MKM Partners analyst Michael Genovese believes the customer is CenturyLink (<a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a> <font color='red'>-2%</font>), which accounted for 24% of ADTN's total sales in 2016.</li><li>The analyst thinks the <a href=\"https://thefly.com/thestreet/realmoney/index.php/ADTN%3bCTLid2660207/ADTN%3bCTL-Adtran-nearterm-CenturyLink-related-weakness-to-be-temporary-says-MKM-Partners\" target=\"_blank\">weakness should prove temporary</a>, adding that ADTN's performance likely will accelerate into 2019 as the company stands to benefit from 5G spending; MKM trims its ADTN target price to $25 from $27 but keeps its Buy rating.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320475\" data-linked=\"Adtran -14% after warning on Q4 earnings\" data-tweet=\"$ADTN $ADTN $CTL - Adtran -14% after warning on Q4 earnings https://seekingalpha.com/news/3320475-adtranminus-14-after-warning-on-q4-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3320475-adtranminus-14-after-warning-on-q4-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320474\" data-ts=\"1514575153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320474-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FELP' title='Foresight Energy LP'>FELP</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320474\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$FELP $PES $SD - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3320474-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320474-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320472\" data-ts=\"1514573890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320472-volatile-day-for-canadian-marijuana-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile day for Canadian marijuana stocks</a></h4><ul> <li>Huge swings in Aphria (APHQF <font color='red'>-5.4%</font>), Aurora Cannabis (ACBFF <font color='green'>+1.5%</font>), Medreleaf (<a href='https://seekingalpha.com/symbol/MEDFF' title='Medreleaf Corp.'>OTCPK:MEDFF</a> <font color='red'>-3.3%</font>), WEED (<a href='https://seekingalpha.com/symbol/BUDZ' title='WEED, Inc.'>OTCPK:BUDZ</a> <font color='green'>+7%</font>) and Canopy Growth (TWMJF <font color='red'>-10%</font>) caused all five stocks to be halted this afternoon by exchanges in Canada.</li><li>Investors appears to be betting furiously on what the cannabis market will bring in 2018.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3320381-legal-marijuana-arriving-california\" target=\"_blank\">Legal marijuana arriving in California</a> (Dec. 29)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3320472\" data-linked=\"Volatile day for Canadian marijuana stocks\" data-tweet=\"$APHA $APHA $ACB - Volatile day for Canadian marijuana stocks https://seekingalpha.com/news/3320472-volatile-day-for-canadian-marijuana-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3320472-volatile-day-for-canadian-marijuana-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>145&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320467\" data-ts=\"1514570862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320467-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CART' title='Carolina Trust Bank'>CART</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CPSS' title='Consumer Portfolio Services, Inc.'>CPSS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320467\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$QIWI $IIPR $GCAP - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3320467-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320467-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320465\" data-ts=\"1514570832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320465-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='green'>+117%</font>. <a href='https://seekingalpha.com/symbol/WSCI' title='WSI Industries Inc.'>WSCI</a> <font color='green'>+27%</font>.LTEA <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/BCLI' title='BrainStorm Cell Therapeutics Inc.'>BCLI</a> <font color='green'>+17%</font>.<a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SOFO' title='Sonic Foundry, Inc.'>OTC:SOFO</a> <font color='green'>+14%</font>.</li></ul>  <ul>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LINU-OLD' title='LiNiu Technology Group'>LINU-OLD</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-9%</font>. FH <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320465\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$KOSS $WSCI $LBCC - Midday Gainers / Losers https://seekingalpha.com/news/3320465-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3320465-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320463\" data-ts=\"1514569937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCEP\" target=\"_blank\">MCEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320463-mid-con-energy-sells-oil-and-gas-assets-explores-strategic-alternatives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mid-Con Energy sells oil and gas assets, explores strategic alternatives</a></h4><ul>     <li>Mid-Con Energy Partners (<a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='red'>-4%</font>) says it <a href=\"https://seekingalpha.com/pr/17034921-mid-con-energy-partners-lp-announces-sale-southern-oklahoma-assets-hiring-financial-advisor\" target=\"_blank\">sold oil and natural gas assets</a> in its southern Oklahoma core area to Exponent Energy III for $22M.</li>     <li>MCEP also says it hired Sagent Advisors to help explore various financing and strategic alternatives, including potential acquisitions, corporate restructuring and merger opportunities.</li><li>MCEP says it is  in discussions with lenders on an extension to its revolving  credit facility as part of its review of financing alternatives.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320463\" data-linked=\"Mid-Con Energy sells oil and gas assets, explores strategic alternatives\" data-tweet=\"$MCEP - Mid-Con Energy sells oil and gas assets, explores strategic alternatives https://seekingalpha.com/news/3320463-mid-con-energy-sells-oil-and-gas-assets-explores-strategic-alternatives?source=tweet\" data-url=\"https://seekingalpha.com/news/3320463-mid-con-energy-sells-oil-and-gas-assets-explores-strategic-alternatives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320458\" data-ts=\"1514566952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320458-consumers-top-5-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumers - Top 5 Gainers / Losers as of 12:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='green'>+63%</font>. LTEA <font color='green'>+14%</font>.<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MPX' title='Marine Products Corporation'>MPX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320458\" data-linked=\"Consumers - Top 5 Gainers / Losers as of 12:00 PM\" data-tweet=\"$KOSS $LBCC $FUV - Consumers - Top 5 Gainers / Losers as of 12:00 PM https://seekingalpha.com/news/3320458-consumers-top-5-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3320458-consumers-top-5-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320455\" data-ts=\"1514566677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIP\" target=\"_blank\">ANIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320455-ani-pharmaceuticals-acquires-four-astrazeneca-ndas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ANI Pharmaceuticals acquires four AstraZeneca NDAs</a></h4><ul><li>        ANI Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a>) <a href=\"https://seekingalpha.com/pr/17035143-ani-pharmaceuticals-acquires-four-ndas-astrazeneca-46_5-million\" target=\"_blank\">acquires</a> the NDAs and U.S. marketing rights for AstraZeneca&rsquo;s Atacand (hypertension), Atacand HCT, Arimidex (breast cancer), and Casodex (prostate cancer).</li><li>                  ANI paid $46.5M in cash, royalties, and sales-based milestones.    </li><li>                  The products generated a combined $19M in sales during the TTM through October. &nbsp;   </li><li>               ANI also <a href=\"https://seekingalpha.com/pr/17035145-ani-pharmaceuticals-enters-five-year-125-million-senior-secured-credit-facility-citizens-bank\" target=\"_blank\">announces</a> entering a new five-year senior secured credit facility for up to $125M.&nbsp;</li><li>               The facility with Citizens Bank includes a $75M five-year term loan that closed today in support of the NDA purchase.&nbsp;</li><li>               ANI shares are&nbsp;<font color='green'>up 1.1%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320455\" data-linked=\"ANI Pharmaceuticals acquires four AstraZeneca NDAs\" data-tweet=\"$ANIP - ANI Pharmaceuticals acquires four AstraZeneca NDAs https://seekingalpha.com/news/3320455-ani-pharmaceuticals-acquires-four-astrazeneca-ndas?source=tweet\" data-url=\"https://seekingalpha.com/news/3320455-ani-pharmaceuticals-acquires-four-astrazeneca-ndas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320453\" data-ts=\"1514565824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320453-mylanplus-1-on-launch-of-estrace-generic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan +1% on launch of Estrace generic</a></h4><ul><li>        Mylan (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>) <a href=\"https://seekingalpha.com/pr/17035176-mylan-adds-u-s-womens-healthcare-portfolio-fda-approval-first-generic-estrace-cream\" target=\"_blank\">announces</a> the U.S. launch of Estradiol Vaginal Cream USP, 0.01%, which is the first generic version of Allergan&rsquo;s Estrace.</li><li>               The product treats vulvar and vaginal atrophy.&nbsp;</li><li>               Estradiol had U.S. sales of about $449M for the twelve months ending October 31.&nbsp;</li><li>               Mylan shares are&nbsp;<font color='green'>up 1%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320453\" data-linked=\"Mylan +1% on launch of Estrace generic\" data-tweet=\"$MYL - Mylan +1% on launch of Estrace generic https://seekingalpha.com/news/3320453-mylanplus-1-on-launch-of-estrace-generic?source=tweet\" data-url=\"https://seekingalpha.com/news/3320453-mylanplus-1-on-launch-of-estrace-generic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320450\" data-ts=\"1514564415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320450-gnc-holdings-rallies-after-fitch-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GNC Holdings rallies after Fitch update</a></h4><ul> <li>Fitch Ratings upgrades its default rating on GNC Holdings (<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a> <font color='green'>+10.1%</font>) to CCC from RD (restricted default) on completion of the company's debt exchange. GNC's senior secured facility is lowered to B-/RR2 from B+/RR2.</li> <li>Fitch on GNC: \"While GNC's exchange modestly reduces the company's total debt burden, it also highlights GNC's challenges in addressing upcoming maturities after recent operating declines and the December 2017 withdrawal of its proposed credit facility refinancing. Fitch remains concerned about the company's ability to address upcoming maturities ($300 million revolver due September 2018 and $1.1 billion term loan maturity in March 2019). GNC's inability to successfully address its upcoming maturities in a timely fashion would be a rating concern.\"</li> <li><a href=\"https://www.fitchratings.com/site/pr/1034643\" target=\"_blank\">Full Fitch report</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3320450\" data-linked=\"GNC Holdings rallies after Fitch update\" data-tweet=\"$GNC - GNC Holdings rallies after Fitch update https://seekingalpha.com/news/3320450-gnc-holdings-rallies-after-fitch-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3320450-gnc-holdings-rallies-after-fitch-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320449\" data-ts=\"1514564230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNT\" target=\"_blank\">SYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320449-syntelminus-5_4-on-wells-fargo-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syntel -5.4% on Wells Fargo downgrade</a></h4><ul><li>        Wells Fargo <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=3&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiaiJiLzq_YAhWm4IMKHTZfAoMQFgg0MAI&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FWells%2BFargo%2BDowngrades%2BSyntel%2C%2BInc.%2B%28SYNT%29%2Bto%2BUnderperform%2BAs%2BWeak%2BPositioning%2BShould%2BDampen%2BGrowthMargin%2BOutlook%2F13636963.html&amp;usg=AOvVaw3wAJsbOQZxtaJHE50wCi4Y\" target=\"_blank\">downgrades</a> Syntel (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNT' title='Syntel, Inc.'>SYNT</a>) from Market Perform to Underperform with a $21 price target.</li><li>               Analyst Ed Caso cites weak positioning in the shifting info tech demand, price pressure on legacy offerings, and limited upside on operating margin. &nbsp;&nbsp;</li><li>               Syntel shares are&nbsp;<font color='red'>down 5.4%</font>&nbsp;to $22.86, which is nearly 9% higher than the Wells Fargo price target.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320449\" data-linked=\"Syntel -5.4% on Wells Fargo downgrade\" data-tweet=\"$SYNT - Syntel -5.4% on Wells Fargo downgrade https://seekingalpha.com/news/3320449-syntelminus-5_4-on-wells-fargo-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3320449-syntelminus-5_4-on-wells-fargo-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320448\" data-ts=\"1514563670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320448-galena-stockholders-ok-merger-sellas-life-sciences\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galena stockholders OK merger with SELLAS Life Sciences</a></h4><ul>     <li>Galena Biopharama (GALE <font color='green'>+8.6%</font>) is higher after shareholders <a href=\"https://seekingalpha.com/pr/17035144-galena-biopharma-inc-stockholders-approve-business-combination-sellas-life-sciences-group-ltd\" target=\"_blank\">approve the company's merger deal</a> with SELLAS Life Sciences.</li>     <li>GALE also says it will implement a reverse stock split of its common shares at a 1\u2011for-30 ratio, to become effective after today's close.</li>     <li>The continuing company, which will be renamed SELLAS Life Sciences, will begin trading on NASDAQ on a post-reverse split basis under the new SLS ticker on Tue., Jan. 2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320448\" data-linked=\"Galena stockholders OK merger with SELLAS Life Sciences\" data-tweet=\"$SLS - Galena stockholders OK merger with SELLAS Life Sciences https://seekingalpha.com/news/3320448-galena-stockholders-ok-merger-sellas-life-sciences?source=tweet\" data-url=\"https://seekingalpha.com/news/3320448-galena-stockholders-ok-merger-sellas-life-sciences\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320447\" data-ts=\"1514563496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320447-delcath-updates-on-convertible-note-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delcath updates on convertible note agreement</a></h4><ul> <li>Delcath Systems (<a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+21.2%</font>)&nbsp;announces that it entered into exchange agreements with an investor from its June 2016 private placement of senior secured convertible notes to extinguish outstanding obligations.</li><li>The agreement sees a release of restrictions on cash held in control accounts and the issuance of shares.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17035109-delcath-announces-exit-convertible-note\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3320447\" data-linked=\"Delcath updates on convertible note agreement\" data-tweet=\"$DCTH - Delcath updates on convertible note agreement https://seekingalpha.com/news/3320447-delcath-updates-on-convertible-note-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3320447-delcath-updates-on-convertible-note-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320428\" data-ts=\"1514563236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320428-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+18%</font>.<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/RSLS' title='ReShape Lifesciences Inc.'>OTC:RSLS</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/RTIX' title='RTI Surgical, Inc.'>RTIX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320428\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$ATRA $INSYQ $CRSP - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3320428-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3320428-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320443\" data-ts=\"1514562353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIVO\" target=\"_blank\">TIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320443-thestreet-tivo-gets-buyout-interest-20-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheStreet: TiVo gets buyout interest at more than $20/share</a></h4><ul>     <li>TiVo (<a href='https://seekingalpha.com/symbol/TIVO' title='TiVo Inc.'>TIVO</a> <font color='green'>+10.4%</font>) spikes higher following a report by TheStreet.com that several potential P-E buyers have <a href=\"https://www.thestreet.com/story/14431925/1/buyout-firms-bid-for-tivo-sources.html\" target=\"_blank\">expressed interest in a buyout</a> that would value the company at ~$2.5B.</li>     <li>The buyers reportedly offered slightly more than $20/share, significantly higher than yesterday's $14 closing price.</li>     <li>TiVo has not launched a strategic review process, according to the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320443\" data-linked=\"TheStreet: TiVo gets buyout interest at more than $20/share\" data-tweet=\"$TIVO - TheStreet: TiVo gets buyout interest at more than $20/share https://seekingalpha.com/news/3320443-thestreet-tivo-gets-buyout-interest-20-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3320443-thestreet-tivo-gets-buyout-interest-20-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320442\" data-ts=\"1514562277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320442-astrazenecaplus-2_1-on-jpmorgan-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca +2.1% on JPMorgan upgrade</a></h4><ul><li>        JPMorgan Chase <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=4&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwj8h9H6xq_YAhVK4oMKHYesBK4QFgg8MAM&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FJPMorgan%2BUpgrades%2BAstraZeneca%2B%28AZN%29%2Bto%2BOverweight%2C%2BStrong%2BGrowth%2BTrajectory%2F13637002.html&amp;usg=AOvVaw2_pXY64teK3s9inxq8hsTX\" target=\"_blank\">upgrades</a> AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>) from Neutral to Overweight.</li><li>               Analyst Richard Vosser cites a strong 2018 growth trajectory for the company after lessened downside risks from the MYSTIC trial failure and exaggerated base business expectations.&nbsp;</li><li>               AstraZeneca shares are&nbsp;<font color='green'>up 2.1%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3282146-astrazeneca-15-percent-premarket-failed-late-stage-study-lung-cancer-candidate-durvalumab\" target=\"_blank\">AstraZeneca down 15% premarket on failed late-stage study on lung cancer candidate durvalumab; Merck up 5% on improved prospects for Keytruda</a> (July 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320442\" data-linked=\"AstraZeneca +2.1% on JPMorgan upgrade\" data-tweet=\"$AZN - AstraZeneca +2.1% on JPMorgan upgrade https://seekingalpha.com/news/3320442-astrazenecaplus-2_1-on-jpmorgan-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3320442-astrazenecaplus-2_1-on-jpmorgan-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320441\" data-ts=\"1514561431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLB\" target=\"_blank\">WLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320441-government-says-wrongly-announced-westmoreland-mine-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Government says it wrongly announced Westmoreland mine expansion</a></h4><ul>     <li>Westmoreland Coal (<a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-5.4%</font>) sinks following yesterday's news that the U.S. Department of the Interior <a href=\"http://flatheadbeacon.com/2017/12/28/officials-say-wrongly-announced-montana-coal-mine-expansion/\" target=\"_blank\">incorrectly announced</a> approval of the company's expansion of its Rosebud mine in Montana.</li>     <li>The Department said an &ldquo;internal miscommunication&rdquo; led to the incorrect announcement last week about the mine expansion, and the project remains under review.</li><li>WLB shares surged nearly 50% in intraday trading Tuesday on the belief that the mine expansion had been approved.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3320441\" data-linked=\"Government says it wrongly announced Westmoreland mine expansion\" data-tweet=\"$WLB - Government says it wrongly announced Westmoreland mine expansion https://seekingalpha.com/news/3320441-government-says-wrongly-announced-westmoreland-mine-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3320441-government-says-wrongly-announced-westmoreland-mine-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320440\" data-ts=\"1514561006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSRT\" target=\"_blank\">MSRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320440-massroots-pops-on-blockchain-pivot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MassRoots pops on blockchain pivot</a></h4><ul> <li>MassRoots (<a href='https://seekingalpha.com/symbol/MSRT' title='MassRoots, Inc.'>OTCQB:MSRT</a> <font color='green'>+22.7%</font>) pops after&nbsp;announcing that it formed the MassRoots Blockchain Technologies subsidiary to developing blockchain-based solutions for the cannabis industry.</li> <li>\"We believe blockchain has the potential to enable the cannabis industry to operate more efficiently and with a greater degree of accountability and transparency,\" says MassRoots CEO&nbsp;Isaac Dietrich.</li><li>Investors seem to agree with volume on MSRT already 2X normal daily activity.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17035089-massroots-forms-subsidiary-blockchain-based-solutions-cannabis-industry\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3320440\" data-linked=\"MassRoots pops on blockchain pivot\" data-tweet=\"$MSRT - MassRoots pops on blockchain pivot https://seekingalpha.com/news/3320440-massroots-pops-on-blockchain-pivot?source=tweet\" data-url=\"https://seekingalpha.com/news/3320440-massroots-pops-on-blockchain-pivot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320434\" data-ts=\"1514559809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WATT\" target=\"_blank\">WATT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320434-citron-research-tweets-energous-history-of-deception-shares-drop-6_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron Research tweets Energous&#39; &quot;history of deception&quot;; shares drop 6.4%</a></h4><ul><li>        Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) shares&nbsp;<font color='red'>drop 6.4%</font>&nbsp;after short-seller Citron Research <a href=\"https://twitter.com/CitronResearch/status/946752806391652352\" target=\"_blank\">calls out</a> the company&rsquo;s &ldquo;history of deception&rdquo; on Twitter.</li><li>               Full Citron tweet: &ldquo;Co has a history of deception and the recent FCC info is no different. Tech is not ready for primetime and the loss of Apple for Dialog, death to the rumor. Roth upgrade was as ridic as their defense of Unipixel until BK. Powercast at CES will expose why WATT to $15.&rdquo;&nbsp;</li><li>                  Background: Energous and Powercast both received FCC certification for wire-free charging technology this week. The companies will each present at CES in January.   </li><li>               Apple is reported designing its own power-management chips for future iPhones, which <a href=\"https://seekingalpha.com/news/3315381-nikkei-apple-will-design-main-power-management-chips-iphones-update\" target=\"_blank\">cut Dialog Semiconductor</a> out of the supply chain, and went with the competing <a href=\"https://seekingalpha.com/news/3295750-idt-passes-30m-shipped-qi-transmitters\" target=\"_blank\">Qi standard</a> for wireless charging. Citron suggests these movements end rumors that Energous could become an Apple supplier.&nbsp;</li><li>Citron also advises not to listen to Roth&rsquo;s defense of Energous as the firm defended Uni-Pixel ahead of its bankruptcy earlier this year. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320092-energous-plus-63-percent-fcc-certification\" target=\"_blank\">Energous +63% on FCC certification</a> (Dec. 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320307-roth-capital-raises-energous-price-target-fcc-chair-tweets-confirmation\" target=\"_blank\">Roth Capital raises its Energous price target; FCC chair tweets confirmation</a> (Dec. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320325-energous-competitor-receives-fcc-approval\" target=\"_blank\">Energous competitor receives FCC approval</a> (Dec. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320434\" data-linked=\"Citron Research tweets Energous&#39; &quot;history of deception&quot;; shares drop 6.4%\" data-tweet=\"$WATT - Citron Research tweets Energous&#39; &quot;history of deception&quot;; shares drop 6.4% https://seekingalpha.com/news/3320434-citron-research-tweets-energous-history-of-deception-shares-drop-6_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3320434-citron-research-tweets-energous-history-of-deception-shares-drop-6_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320426\" data-ts=\"1514557302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCAP\" target=\"_blank\">GCAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320426-super-spike-in-gain-capital-possible-today-says-bull-shares-up-another-28\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Super spike&#39; in Gain Capital possible today, says bull; shares up another 28%</a></h4><ul><li>Gain Capital (NYSE:<a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a>)&nbsp;<font color='green'>rose more than 25%</font>&nbsp;yesterday after <a href=\"https://seekingalpha.com/article/4134290-bitcoin-rollout-send-gain-capital-sharply-higher\" target=\"_blank\">Richard Pearson picked the</a> broker as a blockchain play with an actual real business.</li><li>Shares are&nbsp;<font color='green'>up another 28%&nbsp;</font>in premarket action, with Pearson <a href=\"http://moxreports.com/gcap-superspike/\" target=\"_blank\">suggesting a \"super spike\" as</a> possible in the year's final trading session.</li><li>He notes the \"Dinner Table Effect,\" in which crypto assets spiked higher following Thanksgiving and Xmas. Markets adjust quickly, and he now expects traders to buy in front of New Year's.</li><li>There's also the \"let it ride\" effect - with many sitting on big gains, why sell today and have taxes due with your 2018 return, when selling on Tuesday means taxes would be deferred until 2019?</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320331-gain-capital-10-percent-mox-capital-boost\" target=\"_blank\">Gain Capital up 10% on Mox Capital boost</a> (Dec. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320426\" data-linked=\"&#39;Super spike&#39; in Gain Capital possible today, says bull; shares up another 28%\" data-tweet=\"$GCAP - &#39;Super spike&#39; in Gain Capital possible today, says bull; shares up another 28% https://seekingalpha.com/news/3320426-super-spike-in-gain-capital-possible-today-says-bull-shares-up-another-28?source=tweet\" data-url=\"https://seekingalpha.com/news/3320426-super-spike-in-gain-capital-possible-today-says-bull-shares-up-another-28\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320424\" data-ts=\"1514557174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320424-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='green'>+24%</font>&nbsp;on Mox Capital <a href=\"https://seekingalpha.com/news/3320331-gain-capital-10-percent-mox-capital-boost\" target=\"_blank\">boost</a>.</li><li><a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a> <font color='green'>+21%</font>&nbsp;on NDA <a href=\"https://seekingalpha.com/news/3320422-progenics-pharmaceuticals-plus-21-percent-nda-acceptance\" target=\"_blank\">acceptance</a>.</li><li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>&nbsp;<font color='green'>+14%</font>.</li><li><a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/UCTT' title='Ultra Clean Holdings, Inc.'>UCTT</a> <font color='green'>+7%</font>&nbsp;as it will <a href=\"https://seekingalpha.com/news/3320406-huntington-ingalls-set-join-s-and-p-500\" target=\"_blank\">replace</a> SGMS in the SmallCap 600.</li><li><a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a> <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/QIWI' title='QIWI plc'>QIWI</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320424\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$GCAP $PGNX $TEUM - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3320424-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3320424-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320422\" data-ts=\"1514556778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320422-progenics-pharmaceuticalsplus-21-on-nda-acceptance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenics Pharmaceuticals +21% on NDA acceptance</a></h4><ul><li>        Progenics Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a>) <a href=\"https://seekingalpha.com/pr/17035100-progenics-pharmaceuticals-announces-fda-acceptance-new-drug-application-azedra-iobenguane-131\" target=\"_blank\">announces</a> that the FDA has accepted for review its New Drug Application for rare neuroendocrine tumor treatment Azedra. </li><li>               The FDA also granted the request for priority review and set the PDUFA date for April 30.&nbsp;</li><li>               Progenics shares are&nbsp;<font color='green'>up 20.5%</font>&nbsp;premarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320422\" data-linked=\"Progenics Pharmaceuticals +21% on NDA acceptance\" data-tweet=\"$PGNX - Progenics Pharmaceuticals +21% on NDA acceptance https://seekingalpha.com/news/3320422-progenics-pharmaceuticalsplus-21-on-nda-acceptance?source=tweet\" data-url=\"https://seekingalpha.com/news/3320422-progenics-pharmaceuticalsplus-21-on-nda-acceptance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320421\" data-ts=\"1514556434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320421-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/LINU-OLD' title='LiNiu Technology Group'>LINU-OLD</a> <font color='red'>-7%</font>.</li><li>FH <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3320421\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$LIVE $LINU-OLD $XSPA - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3320421-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3320421-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320416\" data-ts=\"1514554811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320416-pareteum-appoints-cto-and-coo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum appoints CTO and COO</a></h4><ul><li>        Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <a href=\"https://seekingalpha.com/pr/17035078-pareteum-drives-innovation-bolsters-strength-mobile-payment-solution-appointing-ali-davachi\" target=\"_blank\">appoints</a> Ali Davachi as CTO and COO.</li><li>               Davachi previously worked as the Chief Information Security Officer and SVP of Technology at Scivantage and founded Realware.&nbsp;</li><li>                  Pareteum shares are&nbsp;<font color='green'>up 11.7%</font>&nbsp;premarket.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3320078-parateum-adds-cryptocurrency-support-shares-plus-61-percent\" target=\"_blank\">Parateum adds cryptocurrency support, shares +61%</a> (Dec. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320416\" data-linked=\"Pareteum appoints CTO and COO\" data-tweet=\"$TEUM - Pareteum appoints CTO and COO https://seekingalpha.com/news/3320416-pareteum-appoints-cto-and-coo?source=tweet\" data-url=\"https://seekingalpha.com/news/3320416-pareteum-appoints-cto-and-coo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320411\" data-ts=\"1514553559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVDL\" target=\"_blank\">AVDL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320411-avadel-pharmaceuticals-issues-2018-corporate-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avadel pharmaceuticals issues 2018 corporate outlook</a></h4><ul> <li>Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <a href=\"https://seekingalpha.com/pr/17035066-avadel-pharmaceuticals-issues-2018-corporate-outlook\" target=\"_blank\">announces</a> its 2018 corporate objectives and financial expectations.</li>    <li>For 2018, the Company has set forth the following expectations:</li><li>Commercial launch for Noctiva during Q2 2018.</li><li>NDA filing for FT218 by end of 2018 and for AV001&nbsp;in 2019.</li><li>Total Revenues expected in the range of $110M - $130M.</li><li>R&amp;D and SG&amp;A Expenses in the range of $40M - $50M and $85M - $95M respectively.</li>        <li>Avadel is progressing in enrolling patients for its REST-ON Phase III clinical trial.</li>      <li>2017 Total Revenues in the range of $165M to $175M and EPS at the top end of its adjusted EPS guidance of $0.25 to $0.35.</li><li>Shares are down&nbsp;<font color='red'>7%</font>&nbsp;premarket on light volume.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3320411\" data-linked=\"Avadel pharmaceuticals issues 2018 corporate outlook\" data-tweet=\"$AVDL - Avadel pharmaceuticals issues 2018 corporate outlook https://seekingalpha.com/news/3320411-avadel-pharmaceuticals-issues-2018-corporate-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3320411-avadel-pharmaceuticals-issues-2018-corporate-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320408\" data-ts=\"1514552912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RENN\" target=\"_blank\">RENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320408-renren-will-acquire-trucking-app-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renren will acquire trucking app company</a></h4><ul><li>        Renren (NYSE:<a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a>) will acquire Trucker Path, a social platform provider for the U.S. trucking industry. No financial terms were disclosed.</li><li>               Trucker Path created the Trucker Path app for trip planning including real-time updates of points of interest including parking, rest areas, and DOT weight stations.&nbsp;</li><li>                  Renren shares are&nbsp;<font color='green'>up 2.9%</font>&nbsp;premarket.&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; </li><li>Related ETFs: <a href='https://seekingalpha.com/symbol/EMQQ' title='Emerging Markets Internet & Ecommerce ETF'>EMQQ</a>, <a href='https://seekingalpha.com/symbol/KEMQ' title='KraneShares Emerging Markets Consumer Technology ETF'>KEMQ</a>, <a href='https://seekingalpha.com/symbol/SOCL' title='Global X Social Media Index ETF'>SOCL</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3320408\" data-linked=\"Renren will acquire trucking app company\" data-tweet=\"$RENN $RENN $EMQQ - Renren will acquire trucking app company https://seekingalpha.com/news/3320408-renren-will-acquire-trucking-app-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3320408-renren-will-acquire-trucking-app-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320402\" data-ts=\"1514551306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320402-ibm-priceline-settle-lengthy-patent-lawsuit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM, Priceline settle lengthy patent lawsuit</a></h4><ul><li>        IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) and Priceline (PCLN) <a href=\"https://seekingalpha.com/pr/17034957-priceline-com-ibm-settle-patent-lawsuits\" target=\"_blank\">resolve</a> the patent lawsuit with a confidential settlement and cross-licenses to each other&rsquo;s patent portfolio.</li><li>               The patent case <a href=\"https://arstechnica.com/tech-policy/2015/02/ibm-sues-priceline-over-patents-because-prodigy-was-cool/\" target=\"_blank\">goes back to 2015</a> with the patents in question stretching back to the early days of the internet.&nbsp;</li><li>               IBM accused Priceline (and its affiliates Kayak and OpenTable) of violating patents for the pre-World Wide Web online service Prodigy.&nbsp;</li><li>               The patents related to app and ad displays based more on the user computer than the service&rsquo;s servers.&nbsp;</li><li>               In September of this year, a judge handed out a <a href=\"https://www.law360.com/articles/965278/priceline-gets-partial-win-in-ibm-patent-infringement-suit\" target=\"_blank\">complicated split ruling</a> in the case that likely led to the settlement. &nbsp;&nbsp;</li><li>               IBM shares are&nbsp;<font color='green'>up 0.3%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3320402\" data-linked=\"IBM, Priceline settle lengthy patent lawsuit\" data-tweet=\"$IBM $IBM $BKNG - IBM, Priceline settle lengthy patent lawsuit https://seekingalpha.com/news/3320402-ibm-priceline-settle-lengthy-patent-lawsuit?source=tweet\" data-url=\"https://seekingalpha.com/news/3320402-ibm-priceline-settle-lengthy-patent-lawsuit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3320398\" data-ts=\"1514550184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPW\" target=\"_blank\">DPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3320398-digital-powerplus-5_7-on-annual-meeting-details\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Power +5.7% on annual meeting details</a></h4><ul><li>        Digital Power (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) <a href=\"https://seekingalpha.com/pr/17035011-digital-power-corp-achieves-corporate-milestones-annual-meeting\" target=\"_blank\">releases</a> details about its annual shareholder meeting including the approved reorganization strategy and name change to DPW Holdings, effective at the close of business today.</li><li>               The company says its December 31 balance sheet will include $2.5M in cash and securities, short-term debt of $4M, and conversion of Series C stock into common stock.&nbsp;</li><li>               Digital Power shares are&nbsp;<font color='green'>up 5.7%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317978-digital-power-launches-crypto-mining-division-shares-30-percent\" target=\"_blank\">Digital Power launches crypto mining division; shares up 30%</a> (Dec. 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320121-digital-power-plus-11_3-percent-cryptocurrency-mining-addition\" target=\"_blank\">Digital Power +11.3% on cryptocurrency mining addition</a> (Dec. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3320398\" data-linked=\"Digital Power +5.7% on annual meeting details\" data-tweet=\"$DPW - Digital Power +5.7% on annual meeting details https://seekingalpha.com/news/3320398-digital-powerplus-5_7-on-annual-meeting-details?source=tweet\" data-url=\"https://seekingalpha.com/news/3320398-digital-powerplus-5_7-on-annual-meeting-details\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":28,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}